NRIX vs TM · rev $54.5M vs P/E 9.7, rev $234.60B
Nurix Therapeutics Inc (NRIX) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
NRIX currently screens at market cap $1.77B. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the NRIX and TM stock pages for the full models.
Not investment advice.